Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Avanti Helium Corp V.AVN.WT.A


Primary Symbol: V.AVN Alternate Symbol(s):  ARGYF | V.AVN.WT

Energy Oil & Gas E&P
Avanti Helium Corp. is a Canada-based gas exploration company. The Company is focused on helium exploration and development resources across Western Canada and the United States. Its projects include Greater Knappen Project and Leader Project. The Greater Knappen Project has identified key areas for helium exploration in Southern Alberta and Montana. The project covers an area of approximately... see more

Showcase News Releases

Showcase news

i3 Energy Plc.
i3 Energy PLC Announces Result of AGM
Permex Petroleum Corp
Permex Petroleum Announces Appointment of Mr. Brad Taillon, CEO, to the Board of Directors as Well as Additional Board Updates
Kane Biotech Inc.
Kane Biotech Makes First Commercial Sale of revyve(TM) Antimicrobial Wound Gel to ProgenaCare Global

More Showcase News Releases »